Kerala plans vigilance scrutiny of previous drug purchases

Kerala's Health Minister K Muraleedharan has announced an investigation into the previous Left Democratic Front government's purchase of medicines for children with spinal muscular atrophy (SMA). The probe will focus on transactions involving Kannur-based Taurus Remedies Private Limited. Muraleedharan questioned the company's eligibility and the procurement procedures, suggesting the inquiry would examine whether any improper benefits arose.

The inquiry would consider purchases worth approximately Rs 4 crore between 2020 and 2026. This move comes after the opposition challenged the handling of SMA medication, questioning the distribution of medicines with labels referring to clinical trials or physicians' samples. The government has opted for a lower-cost generic formulation, Natsmart, produced by Natco Pharma, instead of the original Evrysdi brand.

Muraleedharan defended the change, stating it followed expert advice and treating doctors had addressed parents' concerns. However, questions remain about the packaging of certain supplies and the distribution process.